Jul 162014


Bioethicist Jennifer Miller, PhD, inaugural George C. Lamb, Jr. Regulatory Fellow, will present a paper entitled “Ethics and Trustworthiness in the Pharmaceutical Industry: Could Rating Help?” Dr. Miller’s talk will debut preliminary results for the rating system she created and is piloting to address ethics and global health concerns about the pharmaceutical industry. The pilot index ranks the 20 largest drug companies on their transparency in disseminating clinical trial results for newly approved drugs — addressing the concern that there is missing and misleading information about new medicines and vaccines that can compromise medical evidence, patient care and public health. The rating system works on the premises that sunlight can be a good disinfectant and that naming good practices and shaming bad ones can incentivize trustworthy reform within the industry where needed.

Dr. Miller is a lab fellow in the Edmond J. Safra Center for Ethics at Harvard University and has taught in Columbia University’s Bioethics and Cross Cultural Education Program and in Fordham University’s Schools of Business. She holds a PhD in Bioethics from Regina Apostolorum and a BS in physics from Fordham University.

Jennifer Miller will be speaking on October 6th as part of the Monday Seminar Series from 12:00-1:15 p.m. in 101 West Duke Building. For lunch, and to receive a copy of the paper draft we’ll be discussing, please email Bashar Alobaidi for RSVP information: bashar.alobaidi@duke.edu.

 July 16, 2014